Literature DB >> 18398809

Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme.

Chamukuttan Snehalatha1, Simon Mary, Vasant V Joshi, Ambady Ramachandran.   

Abstract

In subjects with impaired glucose tolerance (IGT) who participated in the Indian Diabetes Prevention Programme (IDPP), abnormalities related to body mass index, waist circumference (WC), blood pressure (BP), lipid profile and electrocardiography were analysed (at baseline and third-year follow-up) in control, lifestyle modification (LSM), metformin (MET) and LSM + MET groups. At baseline, elevated levels of low-density lipoprotein cholesterol (LDL-C) showed the highest (78.6%) and total cholesterol (TC) showed the lowest (42%) prevalence. At follow-up, prevalence of hypertension (BP > or = 130/> or = 85 mmHg) had increased significantly in all groups. Cardiovascular abnormalities were lower in intervention groups, with the lowest rates in the MET group (p=0.013 vs. control); the LDL-C level decreased in intervention groups. In this programme, Asian Indian IGT subjects were observed to have a high prevalence of cardiovascular risk factors. LSM and MET had beneficial effects on the atherogenic phenotype of lipids but had no influence on blood pressure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398809     DOI: 10.3132/dvdr.2008.005

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  12 in total

Review 1.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

Review 2.  Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials.

Authors:  Anne Karen Jenum; Idunn Brekke; Ibrahimu Mdala; Mirthe Muilwijk; Ambady Ramachandran; Marte Kjøllesdal; Eivind Andersen; Kåre R Richardsen; Anne Douglas; Genevieve Cezard; Aziz Sheikh; Carlos A Celis-Morales; Jason M R Gill; Naveed Sattar; Raj S Bhopal; Erik Beune; Karien Stronks; Per Olav Vandvik; Irene G M van Valkengoed
Journal:  Diabetologia       Date:  2019-06-15       Impact factor: 10.122

Review 3.  Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.

Authors:  Ronald B Goldberg; Kieren Mather
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 4.  Sex-specific differences in diabetes prevention: a systematic review and meta-analysis.

Authors:  Anna Glechner; Jürgen Harreiter; Gerald Gartlehner; Sonja Rohleder; Alexander Kautzky; Jaakko Tuomilehto; Megan Van Noord; Angela Kaminski-Hartenthaler; Alexandra Kautzky-Willer
Journal:  Diabetologia       Date:  2014-12-03       Impact factor: 10.122

Review 5.  Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.

Authors:  Olalekan A Uthman; Louise Hartley; Karen Rees; Fiona Taylor; Shah Ebrahim; Aileen Clarke
Journal:  Cochrane Database Syst Rev       Date:  2015-08-04

Review 6.  Early diagnosis and prevention of diabetes in developing countries.

Authors:  Ramachandran Ambady; Snehalatha Chamukuttan
Journal:  Rev Endocr Metab Disord       Date:  2008-07-07       Impact factor: 9.306

Review 7.  Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.

Authors:  Ulrike Hostalek; Mike Gwilt; Steven Hildemann
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 8.  Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.

Authors:  William T Cefalu; John B Buse; Jaakko Tuomilehto; G Alexander Fleming; Ele Ferrannini; Hertzel C Gerstein; Peter H Bennett; Ambady Ramachandran; Itamar Raz; Julio Rosenstock; Steven E Kahn
Journal:  Diabetes Care       Date:  2016-06-09       Impact factor: 19.112

9.  Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.

Authors:  Kasper S Madsen; Yuan Chi; Maria-Inti Metzendorf; Bernd Richter; Bianca Hemmingsen
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

10.  A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial.

Authors:  Mahen Wijesuriya; Nikolaos Fountoulakis; Nicola Guess; Sarath Banneheka; Laksha Vasantharajah; Martin Gulliford; Giancarlo Viberti; Luigi Gnudi; Janaka Karalliedde
Journal:  BMC Med       Date:  2017-08-30       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.